Metabolomics and Metabolic Diseases: Where do we stand?

By Christopher B. Newgard. Cell Metabolism, 2016

668 citations recorded by the source corpus.

Metabolomics, or the comprehensive profiling of small molecule metabolites in cells, tissues, or whole organisms, has undergone a rapid technological evolution in the past two decades. These advances have led to application of metabolomics for defining predictive biomarkers for incident cardiometabolic diseases, and increasingly, as a blueprint for understanding their pathophysiologic mechanisms. Progress in this area and challenges for the future are reviewed here.

Subfields: Epidemiology, Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/ee0011df729d28d8b6cecd4b621b2c8fd2e343fd